Letairis Related Clinical Trials
A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis [Recruiting]
Ambrisentan in Patients With Porto-pulmonary Hypertension A Multicenter Open Label Trial [Recruiting]
Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary Hypertension [Recruiting]
Study of Ambrisentan With Antifibrotic Agent Combination Therapy in Diffuse Systemic Sclerosis [Recruiting]
ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis [Recruiting]
Study of Ambrisentan and Phosphodiesterase Type-5 Inhibitor (PDE-5i) to Treat Pulmonary Arterial Hypertension [Recruiting]
Safety and Efficacy Trial to Treat Diastolic Heart Failure Using Ambrisentan [Recruiting]
Ambrisentan for Treatment of Portopulmonary Hypertension [Recruiting]
Efficacy and Safety of Ambrisentan in Children 8-18yrs [Recruiting]
Pharmacogenomics in Pulmonary Arterial Hypertension [Recruiting]
Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan [Recruiting]
(ARTEMIS-IPF)Randomized, Placebo-Controlled Study to Evaluate Safety and Effectiveness of Ambrisentan in IPF [Recruiting]
An Observational Study For Ambrisentan [Recruiting]
An Open-Label Uncontrolled Study of the Safety and Efficacy of Ambrisentan in Patients With Exercise Induced Pulmonary Arterial Hypertension and Diastolic Dysfunction [Recruiting]
Long-term Ambrisentan Extension Study for Pediatric Patients Who Participated in AMB112529 [Recruiting]
Safely Change From Bosentan to Ambrisentan in Pulmonary Hypertension [Recruiting]
Influence of CYP3A4-induction by St. John's Wort (SJW) on the Steady State Pharmacokinetics of Ambrisentan [Recruiting]
A Study to Evaluate the Efficacy of an Oral Medication in the Treatment and Prevention of Digital Ulcers in Patients With Systemic Sclerosis (Scleroderma). [Recruiting]
Study of Incidence of Respiratory Tract Adverse Events in Patients Treated With TyvasoŽ Compared to Other FDA Approved Pulmonary Arterial Hypertension (PAH) Therapies [Recruiting]
Examination of the Bronchoprotective Effect of Endothelin Receptor Blockade in Asthma [Not yet recruiting]
Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension [Recruiting]
Registry of Sarcoidosis Associated Pulmonary Hypertension (RESAPH) [Recruiting]
A Study to Evaluate GSK1325760A - a Long-Term Extension Study [Recruiting]
Evaluate the Efficacy, Safety and Pharmacokinetics of GSK1325760A in the Treatment of Pulmonary Arterial Hypertension [Recruiting]
A Study of Ranolazine Acute Administration and Short Term Administration in Pulmonary Arterial Hypertension [Recruiting]
|
